Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Nominee Is Crawford: Choice Emphasizes Continuity, Cooperation

Feb 21 2005

• By The Pink Sheet

Related Content

CDER May Form New Office Of Drug Evaluation For CBER Reviewers

Jan 20 2003

PhRMA Is Critical To “Critical Path,” Crawford Says; Communication Is Key

Apr 12 2004

FDA Generic Biologics “Structure” To Come Soon; Policy Debate In 2005

Apr 05 2004

Drug Safety Changes Should Await IoM, HHS Secretary Tells Congress

Feb 07 2005

FDA Unveils Rx Safety Board, Website; Postmarket Surveillance Overhaul Next

Feb 21 2005

FDA Commissioner Choices Appear To Be Crawford Or Long Wait

Nov 08 2004

FDA Talking Tough On DTC: Is Viagra Letter First Of Many?

Nov 22 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window